RxDoctor Payments DataLook up a doctor →

Amber Wilson

Nurse Practitioner · Macon, GANPI 1437673266

Payments from drug & device makers

$11,743in general payments, 2019–2025

Across 524 payments — averaging $22.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$842
  • Seagen Inc.$840
  • Novartis$664
  • AstraZeneca$656
  • AbbVie$558
  • Johnson & Johnson$540
  • plus $8K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck38$842
Seagen Inc.25$840
Novartis28$664
AstraZeneca(2 entities)36$656
AbbVie24$558
Johnson & Johnson(2 entities)19$540
Daiichi Sankyo Inc.14$420
Astellas Pharma US Inc18$419
Pfizer23$418
Amgen22$417
AVEO Pharmaceuticals, Inc.12$409
Regeneron Healthcare Solutions, Inc.13$317
Sanofi14$307
Takeda Pharmaceuticals U.S.A., Inc.11$306
Gilead(2 entities)11$231
Genentech USA, Inc.11$225
GSK12$214
Bayer11$212
Stemline Therapeutics Inc.8$211
Incyte Corporation12$205
Exelixis Inc.5$182
Karyopharm Therapeutics Inc.8$182
Bristol Myers Squibb9$178
Beigene USA, Inc.9$166
Jazz Pharmaceuticals Inc.7$163
Eisai Inc.8$160
Lilly USA, LLC8$151
Servier Pharmaceuticals LLC7$126
Blueprint Medicines Corporation6$125
Myriad Genetic Laboratories, Inc.6$117
Sun Pharmaceutical Industries Inc.4$104
Coherus Oncology, Inc.6$103
Pharmacyclics LLC, An Abbvie Company5$103
Puma Biotechnology, Inc.6$100
Sanofi-aventis U.S. LLC1$98
E.r. Squibb & Sons, L.L.C.5$96
Adaptive Biotechnologies Corporation5$95
Ipsen Biopharmaceuticals, Inc4$71
Rigel Pharmaceuticals, Inc.3$62
Geron Corporation3$61
Deciphera Pharmaceuticals Inc.3$58
Sobi, Inc3$57
Mirati Therapeutics, Inc.4$55
Agios Pharmaceuticals, Inc.3$54
Tersera Therapeutics LLC2$53
Epizyme, Inc.3$52
ADC Therapeutics America, Inc.3$49
G1 Therapeutics, Inc.2$42
Organon2$41
Emmaus Medical, Inc.2$40
Fresenius Kabi USA, LLC2$38
Pharmacosmos Therapeutics Inc.2$35
Taiho Oncology, Inc.1$35
Morphosys, US Inc.2$34
Iovance Biotherapeutics, Inc.1$32
Springworks Therapeutics, Inc.1$29
Syndax Pharmaceuticals, Inc.1$23
Beone Medicines USA, Inc.1$22
Boehringer Ingelheim1$20
Legend Biotech USA Inc.1$19

How this compares

$11,743 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia →

Medicare billing

Part B allowed, 2024
$24,163
Medicare patients
157
Services billed
269

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Macon

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →